Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.
作者信息
Nisii Carla, Castilletti Concetta, Raoul Hervé, Hewson Roger, Brown David, Gopal Robin, Eickmann Markus, Gunther Stephan, Mirazimi Ali, Koivula Tuija, Feldmann Heinz, Di Caro Antonino, Capobianchi Maria R, Ippolito Giuseppe
机构信息
L. Spallanzani National Institute for Infectious Diseases, Rome, Italy.
出版信息
PLoS Pathog. 2013 Jan;9(1):e1003105. doi: 10.1371/journal.ppat.1003105. Epub 2013 Jan 17.
Abstract
摘要
相似文献
1
Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research.
PLoS Pathog. 2013 Jan;9(1):e1003105. doi: 10.1371/journal.ppat.1003105. Epub 2013 Jan 17.
2
European perspective of 2-person rule for biosafety level 4 laboratories.
Emerg Infect Dis. 2009 Nov;15(11):1858. doi: 10.3201/eid1511.091134.
3
Biosafety practices associated with potential agents of biocrime and biowarfare.
Curr Protoc Microbiol. 2006 Dec;Chapter 1:Unit 1A.2. doi: 10.1002/9780471729259.mc01a02s3.
4
Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
Euro Surveill. 2020 Sep;25(36). doi: 10.2807/1560-7917.ES.2020.25.36.2000089.
5
The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats.
Clin Microbiol Infect. 2009 Aug;15(8):720-6. doi: 10.1111/j.1469-0691.2009.02946.x.
6
Biosafety and biosecurity measures: management of biosafety level 3 facilities.
Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S70-4. doi: 10.1016/j.ijantimicag.2010.06.026. Epub 2010 Aug 30.
7
Biosafety. Boston weighs a ban on biodefense studies.
Science. 2004 Apr 30;304(5671):665. doi: 10.1126/science.304.5671.665.
8
Biosafety lab passes disaster test.
Nature. 2008 Oct 23;455(7216):1012. doi: 10.1038/4551012a.
9
Regulation of biological research in the terrorism era.
Health Matrix Clevel. 2003 Winter;13(1):159-80.
10
Seven Opportunities for Effective Biosafety and Biosecurity Governance.
Health Secur. 2024 Aug;22(4):324-329. doi: 10.1089/hs.2023.0189. Epub 2024 Apr 12.
引用本文的文献
1
Field Deployment of a Mobile Biosafety Laboratory Reveals the Co-Circulation of Dengue Viruses Serotype 1 and Serotype 2 in Louga City, Senegal, 2017.
J Trop Med. 2021 Mar 31;2021:8817987. doi: 10.1155/2021/8817987. eCollection 2021.
2
Field evaluation of a mobile biosafety laboratory in Senegal to strengthen rapid disease outbreak response and monitoring.
Afr J Lab Med. 2020 Aug 20;9(2):1041. doi: 10.4102/ajlm.v9i2.1041. eCollection 2020.
3
Harmonization of Biosafety and Biosecurity Standards for High-Containment Facilities in Low- and Middle-Income Countries: An Approach From the Perspective of Occupational Safety and Health.
Front Public Health. 2019 Sep 12;7:249. doi: 10.3389/fpubh.2019.00249. eCollection 2019.
4
Biosafety Level 4 Laboratory User Training Program, China.
Emerg Infect Dis. 2019 May;25(5). doi: 10.3201/eid2505.180220.
5
International Biological Reference Preparations for Epidemic Infectious Diseases.
Emerg Infect Dis. 2019 Feb;25(2):205-211. doi: 10.3201/eid2502.180798.
6
Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks.
Int J Environ Res Public Health. 2018 Nov 29;15(12):2697. doi: 10.3390/ijerph15122697.
7
Status, quality and specific needs of Ebola virus diagnostic capacity and capability in laboratories of the two European preparedness laboratory networks EMERGE and EVD-LabNet.
Euro Surveill. 2018 May;23(19). doi: 10.2807/1560-7917.ES.2018.23.19.17-00404.
8
Prioritization of High Consequence Viruses to Improve European Laboratory Preparedness for Cross-Border Health Threats.
Adv Exp Med Biol. 2017;972:123-129. doi: 10.1007/5584_2016_152.
9
Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses.
Viruses. 2016 Jul 20;8(7):197. doi: 10.3390/v8070197.
10
Reverse Genetics Approaches to Control Arenavirus.
Methods Mol Biol. 2016;1403:313-51. doi: 10.1007/978-1-4939-3387-7_17.
本文引用的文献
1
The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola.
PLoS Negl Trop Dis. 2011 May;5(5):e1183. doi: 10.1371/journal.pntd.0001183. Epub 2011 May 24.
2
European perspective of 2-person rule for biosafety level 4 laboratories.
Emerg Infect Dis. 2009 Nov;15(11):1858. doi: 10.3201/eid1511.091134.
3
The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats.
Clin Microbiol Infect. 2009 Aug;15(8):720-6. doi: 10.1111/j.1469-0691.2009.02946.x.
4
Potential impact of a 2-person security rule on BioSafety Level 4 laboratory workers.
Emerg Infect Dis. 2009 Jul;15(7):e1. doi: 10.3201/eid1507.081523.
5
Training health care workers to face highly infectious diseases.
Clin Microbiol Infect. 2009 Aug;15(8):740-2. doi: 10.1111/j.1469-0691.2009.02872.x. Epub 2009 May 28.
6
Facing the threat of highly infectious diseases in Europe: the need for a networking approach.
Clin Microbiol Infect. 2009 Aug;15(8):706-10. doi: 10.1111/j.1469-0691.2009.02876.x. Epub 2009 May 28.
7
Networking for infectious-disease emergencies in Europe.
Nat Rev Microbiol. 2008 Jul;6(7):564. doi: 10.1038/nrmicro1896-c1.
8
A curriculum for training healthcare workers in the management of highly infectious diseases.
Euro Surveill. 2007 Jun 1;12(6):E5-6. doi: 10.2807/esm.12.06.00716-en.
9
High-throughput molecular detection of hemorrhagic fever virus threats with applications for outbreak settings.
J Infect Dis. 2007 Nov 15;196 Suppl 2:S205-12. doi: 10.1086/520601.
10
Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004.
J Infect Dis. 2007 Nov 15;196 Suppl 2:S193-8. doi: 10.1086/520609.
Zotero 插件